ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease
{{output}}
Background: Beginning in 2006, neuroradiologists became increasingly aware of the risk of nephrogenic system fibrosis (NSF) when patients suffering from chronic kidney disease (CKD) received gadolinium-based contrast agents (GBCA... ...
